Home Ingredients Serrapeptase (Serratiopeptidase)
Anti-InflammatoryJoint Health

Serrapeptase (Serratiopeptidase)

Serratia E15 (originally) / fermentation-derived
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Serrapeptase is a proteolytic enzyme originally isolated from silkworm intestinal bacteria (Serratia) — now produced via fermentation. Used widely in Japan and Europe (prescription drug status in some countries) for inflammation, sinusitis, fibrocystic breast disease, post-surgical edema, and pain. Anti-inflammatory enzyme that breaks down dead tissue and inflammatory proteins without affecting healthy tissue. Strong observational/clinical practice support but rigorous Western RCT evidence limited.

Studied Dose 10-60 mg/day (typically 10-30 mg/day), standardized to 20,000-80,000 enzymatic units; taken on empty stomach
Active Compound Serrapeptase (serratiopeptidase, serralysin family metalloprotease)

Benefits

Sinusitis and Upper Respiratory Inflammation

Mazzone 1990 and others showed serrapeptase reduces sinusitis symptoms (pain, nasal secretion, obstruction, swelling) compared to placebo. Used widely in Italy, Japan, India for chronic sinusitis adjunct. Mechanism: liquefying mucus and reducing inflammatory mediators.

Supported by Trial 1, Trial 2

Post-Surgical Edema and Pain

Multiple trials (especially in oral/maxillofacial surgery, orthopedic procedures) show serrapeptase reduces post-operative swelling and pain vs placebo. Tachibana 1984 wisdom tooth surgery trial foundational. Used routinely in Japan post-operatively.

Supported by Trial 2

Fibrocystic Breast Disease

RCT showed serrapeptase (5 mg TID) reduced breast pain, swelling, and induration in fibrocystic breast disease vs placebo. Limited subsequent replication but referenced in supplement marketing.

Supported by Trial 1, Trial 2

Carpal Tunnel Syndrome (Limited Evidence)

Panagariya 1999 small trial suggested serrapeptase improves carpal tunnel symptoms. Sample size limited; not standard treatment (which includes wrist splinting, NSAIDs, corticosteroid injection, surgery for refractory cases).

Supported by Trial 2

Atherosclerosis Plaque (Theoretical)

Theoretical mechanism: serrapeptase digests atherosclerotic plaque protein components. Marketed for cardiovascular health based on this mechanism. NO human clinical evidence demonstrating cardiovascular outcomes benefit. Speculative claim.

Supported by Trial 1, Trial 2

Mechanism of action

1

Selective Proteolytic Activity

Serrapeptase digests dead/inflammatory tissue and proteins (fibrin, bradykinin, histamine, C-reactive protein) but not healthy tissue. Selective activity attributed to enzyme's substrate specificity for inflammatory mediators.

2

Bradykinin Reduction

Bradykinin is a major inflammatory mediator causing pain, edema, vasodilation. Serrapeptase degrades bradykinin — basis for anti-inflammatory and analgesic effects.

3

Mucolytic Activity

Serrapeptase breaks down mucoprotein matrix in respiratory mucus — reducing viscosity. Basis for sinusitis, bronchitis, COPD adjunctive use.

4

Enteric Coating Required

Serrapeptase is destroyed by gastric acid — requires enteric coating to deliver intact enzyme to small intestine for absorption. Quality varies dramatically by manufacturer; non-enteric-coated products may be ineffective.

Clinical trials

1
Serrapeptase for Chronic Sinusitis

Multicenter trial of serrapeptase (15 mg BID) vs placebo for chronic sinusitis in 193 patients for 7 days. (J Int Med Res)

193 chronic sinusitis patients.

Serrapeptase significantly reduced sinusitis symptom scores (pain, nasal secretion, obstruction, swelling) vs placebo. Foundational European trial supporting clinical use in sinusitis.

2
Serrapeptase for Post-Surgical Edema

Clinical trial of serrapeptase vs placebo for post-operative swelling after wisdom tooth surgery.

Wisdom tooth extraction patients.

Serrapeptase significantly reduced post-operative edema and pain vs placebo. Foundational trial supporting routine post-surgical use in Japan and Europe.

Side effects and drug interactions

Common Potential side effects

GI distress (nausea, abdominal pain, diarrhea).
Bleeding risk — proteolytic activity may modestly affect coagulation; pre-surgery discontinuation prudent.
Skin reactions, allergic reactions rare.
Pneumonitis (RARE but documented) — interstitial pneumonia case reports in Japanese literature; serious adverse event.
Coughing up blood (rare).
Liver enzyme elevation (rare).
Post-marketing pharmacovigilance in Japan led to RESTRICTED USE — Japanese MHLW revoked some indications based on lack of efficacy in rigorous trials.

Important Drug interactions

Anticoagulants (warfarin, DOACs) — theoretical bleeding risk; monitor.
Antiplatelet drugs (aspirin, clopidogrel) — additive bleeding risk.
NSAIDs — additive bleeding risk and additive anti-inflammatory effects.
Antibiotics — serrapeptase historically promoted to enhance antibiotic penetration into infected tissue; clinical relevance limited.
Other proteolytic enzyme supplements (bromelain, papain, nattokinase) — additive effects; unclear clinical relevance.

More Anti-Inflammatory Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Anti-Inflammatory
Meriva® (Curcumin Phytosome — Indena)
Meriva® is a CURCUMIN PHYTOSOME® formulation developed by Indena (Italy) — using Indena's…
Cognitive
Longvida® Optimized Curcumin (Verdure Sciences)
Longvida® is a PATENTED CURCUMIN EXTRACT developed by Verdure Sciences using SLCP™ (Solid…

Explore Other Ingredients

Antioxidant
Curcumin/Turmeric
Curcumin, the primary bioactive compound in turmeric (Curcuma longa), is commonly suppleme…
Muscle & Recovery
Bromelain
Bromelain is a group of protein-digesting enzymes extracted from pineapple stems, used in…
Sleep Health
Serezin™
Serezin™ is PLT Health Solutions' patented blend of Boswellia serrata and ginger (Zingiber…

Frequently asked questions about Serrapeptase (Serratiopeptidase)

What is serrapeptase?

Serrapeptase is a protein-digesting enzyme originally derived from silkworms. It is taken on an empty stomach and marketed for easing inflammation, swelling, and mucus, and for breaking down excess proteins, though human evidence is limited.

What is serrapeptase used for?

It is used for proposed anti-inflammatory and mucus-thinning effects, such as supporting sinus and respiratory comfort and post-surgical swelling. The supporting research is mostly older or small, so claims should be viewed cautiously.

When should I take serrapeptase?

It is taken on an empty stomach, typically 30 minutes before or a couple of hours after meals, so it is absorbed rather than used on food. Enteric-coated forms are used to survive stomach acid.

Is serrapeptase safe?

It is generally tolerated short-term, but evidence and long-term safety data are limited. It may have a blood-thinning effect, so avoid it with anticoagulants or before surgery, and check with your doctor before use.

What is the recommended dosage of Serrapeptase?

The clinically studied dose is 10-60 mg/day (typically 10-30 mg/day), standardized to 20,000-80,000 enzymatic units; taken on empty stomach Always follow the product label and check with a healthcare provider for personal advice.